GRCE

Grace Therapeutics (GRCE)

About Grace Therapeutics (GRCE)

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.68
52 Week Low
$1.75
Market cap
50.1M
Dividend yield
0.00%
Volume
--
Avg. volume
60,135
P/E ratio
-5.54

Grace Therapeutics News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$4.68
52 Week Low
$1.75
Market cap
50.1M
Dividend yield
0.00%
Volume
--
Avg. volume
60,135
P/E ratio
-5.54